We Can Medicines Co., Ltd. (TPEX:6929)
Taiwan
· Delayed Price · Currency is TWD 27.10
+0.10 (0.37%)
Apr 29, 2026, 1:17 PM CST
We Can Medicines Market Cap
We Can Medicines has a market cap or net worth of 1.22 billion as of April 28, 2026. Its market cap has decreased by -37.06% in one year.
Market Cap
1.22B
Enterprise Value
2.13B
Revenue
3.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
27.10
Market Cap Chart
Since December 9, 2022, We Can Medicines's market cap has decreased from 1.84B to 1.22B, a decrease of -33.87%. That is a compound annual growth rate of -11.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.22B | -21.38% |
| Dec 31, 2025 | 1.55B | -10.72% |
| Dec 31, 2024 | 1.73B | -59.87% |
| Dec 29, 2023 | 4.32B | 13.80% |
| Dec 30, 2022 | 3.80B | 106.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DaBomb Protein Biotech | 1.15B |
| Jia Jie Biomedical | 1.37B |
| Far East Bio-Tec | 1.60B |
| Lian Fa International Dining Business | 1.66B |
| Wonder Pets Enterprises | 2.17B |
| Tai Roun Products | 2.19B |
| Hantech Bio-Technology | 2.39B |
| Ten Ren Tea | 2.61B |